Cargando…

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease

BACKGROUND: In patients with chronic heart failure and chronic kidney disease, correction of anemia with erythropoietin‐stimulating agents targeting normal hemoglobin levels is associated with an increased risk of cardiovascular morbidity and mortality. Emerging data suggest a direct effect of eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisenga, Michele F., Emans, Mireille E., van der Putten, Karien, Cramer, Maarten J., Diepenbroek, Adry, Velthuis, Birgitta K., Doevendans, Pieter A., Verhaar, Marianne C., Joles, Jaap A., Bakker, Stephan J. L., Nolte, Ilja M., Braam, Branko, Gaillard, Carlo A. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759901/ https://www.ncbi.nlm.nih.gov/pubmed/31423921 http://dx.doi.org/10.1161/JAHA.118.011130

Ejemplares similares

Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging
por: Emans, Mireille E, et al.
Publicado: (2012)

Neuronal Nitric Oxide Synthase-Dependent Amelioration of Diastolic Dysfunction in Rats with Chronic Renocardiac Syndrome
por: Bongartz, Lennart G., et al.
Publicado: (2015)

Short-Term Erythropoietin Treatment Does Not Substantially Modulate Monocyte Transcriptomes of Patients with Combined Heart and Renal Failure
por: Jie, Kim E., et al.
Publicado: (2012)

Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome
por: Jie, Kim E, et al.
Publicado: (2010)

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
por: van Breda, Fenna, et al.
Publicado: (2015)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
por: Eisenga, Michele F., et al.
Publicado: (2018)

Consequences of perinatal treatment with l-arginine and antioxidants for the renal transcriptome in spontaneously hypertensive rats
por: Wesseling, Sebastiaan, et al.
Publicado: (2009)

Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study
por: Santos, E.J.F., et al.
Publicado: (2018)

Anti-epoetin-antibody-induced anemia in a child with chronic renal failure
por: Jöbsis, Jasper J., et al.
Publicado: (2010)

Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis
por: Papazova, Diana A., et al.
Publicado: (2015)

Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease
por: Ohashi, Naro, et al.
Publicado: (2012)

Maintenance of Hypertensive Hemodynamics Does Not Depend on ROS in Established Experimental Chronic Kidney Disease
por: Papazova, Diana A., et al.
Publicado: (2014)

Nitric Oxide Synthase Inhibition Induces Renal Medullary Hypoxia in Conscious Rats
por: Emans, Tonja W., et al.
Publicado: (2018)

Circadian Rhythm in Kidney Tissue Oxygenation in the Rat
por: Emans, Tonja W., et al.
Publicado: (2017)

Ex vivo exposure of bone marrow from chronic kidney disease donor rats to pravastatin limits renal damage in recipient rats with chronic kidney disease
por: van Koppen, Arianne, et al.
Publicado: (2015)

Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease
por: Fishbane, Steven, et al.
Publicado: (2019)

Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
por: van de Wouw, Jens, et al.
Publicado: (2019)

Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility
por: Davis-Ajami, Mary Lynn, et al.
Publicado: (2014)

Successful Prolonged Desensitization to Epoetin-Alfa Hypersensitivity in an Adult Patient With Advanced Chronic Kidney Disease
por: Panchal, Hemali, et al.
Publicado: (2023)

Design of a consensus-based geriatric assessment tailored for older chronic kidney disease patients: results of a pragmatic approach
por: Voorend, Carlijn G. N., et al.
Publicado: (2021)

The Use of Epoetin-α in Revision Knee Arthroplasty
por: Delasotta, Lawrence A., et al.
Publicado: (2012)

Quality of Original and Biosimilar Epoetin Products
por: Brinks, Vera, et al.
Publicado: (2010)

Human Embryonic Mesenchymal Stem Cell-Derived Conditioned Medium Rescues Kidney Function in Rats with Established Chronic Kidney Disease
por: van Koppen, Arianne, et al.
Publicado: (2012)

Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease
por: Bartnicki, Piotr, et al.
Publicado: (2013)

Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease
por: Aizawa, Ken, et al.
Publicado: (2018)

Angiotensin II-induced hypertension in rats is only transiently accompanied by lower renal oxygenation
por: Emans, Tonja. W., et al.
Publicado: (2018)

Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury
por: Irrera, Natasha, et al.
Publicado: (2015)

Perinatal Exogenous Nitric Oxide in Fawn-Hooded Hypertensive Rats Reduces Renal Ribosomal Biogenesis in Early Life
por: Wesseling, Sebastiaan, et al.
Publicado: (2011)

The Use of Preoperative Epoetin-α in Revision Hip Arthroplasty
por: Delasotta, Lawrence A, et al.
Publicado: (2012)

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report
por: Behler, Caroline M, et al.
Publicado: (2009)

The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients
por: AlKharboush, Hanan, et al.
Publicado: (2020)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

T-cells contribute to hypertension but not to renal injury in mice with subtotal nephrectomy
por: Oosterhuis, Nynke R., et al.
Publicado: (2017)

Recombinant human epoetin beta in the treatment of renal anemia
por: Locatelli, Francesco, et al.
Publicado: (2007)

Epoetin beta for the treatment of chemotherapy-induced anemia: an update
por: Galli, Luca, et al.
Publicado: (2015)

Epoetin Alfa: A Cause of Coronary Artery Thrombosis
por: Siddiqui, Muhammad Umer, et al.
Publicado: (2017)

Pure red cell aplasia induced by epoetin zeta
por: Panichi, Vincenzo, et al.
Publicado: (2016)

Chronic, Combined Cardiac and Renal Dysfunction Exacerbates Renal Venous Pressure-Induced Suppression of Renal Function in Rats
por: Hamza, Shereen M., et al.
Publicado: (2022)

Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study
por: Belleudi, Valeria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_709i79m4v3e3klpu4lcare48n0